|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-5-28
|
|
pubmed:abstractText |
We examined clinical outcomes, patient characteristics and trends over time of non-medically supervised treatment interruptions (TIs) from a free-of-charge antiretroviral therapy (ART) programme in British Columbia (BC), Canada.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1468-1293
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
299-307
|
|
pubmed:dateRevised |
2011-8-1
|
|
pubmed:meshHeading |
pubmed-meshheading:20002777-Adolescent,
pubmed-meshheading:20002777-Adult,
pubmed-meshheading:20002777-Age Factors,
pubmed-meshheading:20002777-Anti-Retroviral Agents,
pubmed-meshheading:20002777-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:20002777-British Columbia,
pubmed-meshheading:20002777-CD4 Lymphocyte Count,
pubmed-meshheading:20002777-Female,
pubmed-meshheading:20002777-HIV Infections,
pubmed-meshheading:20002777-Health Services Accessibility,
pubmed-meshheading:20002777-Hepatitis C,
pubmed-meshheading:20002777-Humans,
pubmed-meshheading:20002777-Male,
pubmed-meshheading:20002777-Medication Adherence,
pubmed-meshheading:20002777-Pregnancy,
pubmed-meshheading:20002777-Proportional Hazards Models,
pubmed-meshheading:20002777-Substance Abuse, Intravenous,
pubmed-meshheading:20002777-Time Factors,
pubmed-meshheading:20002777-Treatment Outcome,
pubmed-meshheading:20002777-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme.
|
|
pubmed:affiliation |
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada. dmoore@cfenet.ubc.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
